Crushed earnings, but July revenue outlook barely beats expectations, stock down a couple % after hours. What? So they crush and say outlook is better than you guys thought, but just a litle better, so punish us.
CEO: results were above Veeva’s own guidance and included solid operating cash flow!
Sales have only been growing 20% last 4Q. (Ok, we like to see 25-30%, but still).
These guys provide a great cloud-based services for the medical developement industry including Veeva Vault, a cloud-based enterprise content management applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, quality, and safety.
They have been growing their service options, thus creating a “land-and-expand” model that we like here. They do for the medical development industry somewhat what Salesforce does for others, but are highly focused on an industry that requires strong understanding of specific rules and regulations, so their is a decent barrier to entry.
Ranked #3 in its stock group with pretty strong ratings:
Composite Rating 96 Pass
EPS Rating 84 Neutral
RS Rating 87 Pass
Group RS Rating A- Pass
SMR Rating A Pass
Acc/Dis Rating B Pass
Recent breakout price was 75.67, still in a good buy range if you care about that kind of thing.
Strongly followed by some.